Sign in
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration
Journal article   Open access  Peer reviewed

Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration

Mark N Stein, Jyoti Malhotra, Rohinton S Tarapore, Usha Malhotra, Ann W Silk, Nancy Chan, Lorna Rodriguez, Joseph Aisner, Robert D Aiken, Tina Mayer, …
Journal for immunotherapy of cancer, Vol.7(1), pp.136-136
05/22/2019
PMCID: PMC6532211
PMID: 31118108

Abstract

Solid tumors Immuno-oncology ONC201 Cancer Dopamine Immunotherapy
url
https://doi.org/10.1186/s40425-019-0599-8View
Version of Record (VoR) Open

Details